Call your pharmacy directly to ask about their current formulary and compounding policies
however, no dose adjustments are needed based on renal function
In addition, we have not made any adjustments for future changes in variables, such as service volume, service-mix, or number of encounters
The timeframe for observing results also plays a role short-term effects might call for a single, higher dose, while long-term studies may benefit from smaller, repeated doses
Foundayo (orforglipron), developed by Eli Lilly, is a new, once-daily oral GLP-1 weight-loss pill approved in the UAE (second globally after the US) and expected to be available from May 2026
it also indicates whether the accumulation of the drug occurs under a multiple dosage regimen and it is essential to decide on the appropriate dosing intervals